Lonza
NEWS
Financial details of the deal were not disclosed, but Lonza said it plans to retain the Novartis employees currently working at the facility.
Lonza reports restated 2018 financials for sales, CORE EBITDA and CORE EBIT
Lonza Group announced its intention to proceed with a carve-out of its Specialty Ingredients segment.
All investments in healthcare businesses progressing as planned to further accelerate growth
Lonza announced the adjustment of its Mid-Term Guidance 2022 to reflect the divestment of its former Water Care business unit and to emphasize Lonza’s focus on growth along the Healthcare Continuum®.
Lonza announced the completion of the divestment of its former Water Care business and operations to Platinum Equity for USD 630 million.
Lonza announced the internal alignment of its business structure to accelerate growth along the Healthcare Continuum® and strengthen the Microbial Control business.
Lonza announced that Richard Ridinger, CEO, has decided to retire from the company after seven successful years.
Lonza reported a 9% organic sales, 12% organic CORE EBITDA and 14% organic CORE EBIT growth.
JOBS
IN THE PRESS